A novel polyherbal formulation effective as an antimicrobial, Anti-inflammatory, Anti-oxidant

The novel polyherbal formulation PRS-17, combining Aloe Vera and Guggulu extracts with advanced extraction techniques, addresses the need for a comprehensive treatment for inflammatory and antimicrobial conditions, achieving enhanced therapeutic effects and broad-spectrum activity for various health issues.

WO2024231959A1PCT designated stage expired Publication Date: 2024-11-14POLISHETTY RAVISHANKAR
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
PCT/IN2024/050518
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2023-05-10
Filing Date
2024-05-10
Publication Date
2024-11-14

AI Technical Summary

Technical Problem

Current treatments for inflammatory, antimicrobial, and antioxidant conditions lack a comprehensive and effective polyherbal formulation that can address multiple health issues such as arthritis, cardiovascular health, wound healing, and immune system modulation.

Method used

A novel polyherbal formulation, PRS-17, combining Aloe Vera and Guggulu extracts with specific excipients, utilizing advanced extraction techniques to enhance the concentration and bioavailability of active compounds like polysaccharides, anthraquinones, and lectins, creating a synergistic effect for anti-inflammatory, antimicrobial, and antioxidant properties.

Benefits of technology

The formulation demonstrates enhanced therapeutic effects by providing anti-inflammatory, immunomodulatory, and antioxidant benefits, potentially improving conditions like arthritis, cardiovascular health, and immune system regulation, with broad-spectrum activity and versatility in health supplements, pharmaceuticals, and cosmetics.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure IN2024050518_14112024_PF_FP_ABST
    Figure IN2024050518_14112024_PF_FP_ABST
Patent Text Reader

Abstract

The present invention discloses a novel polyhedral formulation PRS-17 with potent 5 antimicrobial, anti-inflammatory, and antioxidant activities. PRS-17 comprises a combination of natural plant extracts and essential oils that have been found to possess high efficacy against a broad range of bacterial and fungal strains. Additionally, the formulation demonstrated potent anti-inflammatory activity by inhibiting the production of pro-inflammatory cytokines, and also displayed robust antioxidant activity by scavenging free radicals. Furthermore, the PRS-17 formulation is shown to be safe for use in humans, making it an ideal candidate for the development of new antimicrobial, anti-inflammatory, and antioxidant agents for a range of applications, including pharmaceuticals, cosmetics, and food products.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] A NOVEL POLYHERBAL FORMULATION EFFECTIVE AS AN ANTIMICROBIAL, ANTI-INFLAMMATORY, ANTI-OXIDANT

[0002] FIELD OF THE INVENTION

[0003] The present invention relates to an herbal formulation and a process for the preparation thereof. Particularly, the present invention also pertains to an oral herbal composition with antiinflammatory, wound-healing, laxative, antiviral, antimicrobial, antioxidant, and immune- modulatory properties.

[0004] BACKGROUND OF THE INVENTION

[0005] Aloe vera is a medicinal plant species of the genus Aloe with a long history of usage around the world. Acemannan, considered one of the main bioactive polysaccharides of Aloe vera, possesses immunoregulation, anti-cancer, anti-oxidation, wound healing, bone proliferation promotion, neuroprotection, and intestinal health promotion activities, among others. The active components of Aloe vera contribute to its diverse effects including polysaccharides like acemannan, anthraquinones, and lectins among others. These components are known for their immunomodulatory, antiglycemic, anti-inflammatory, and laxative effects.

[0006] PRS-17 is a multi -herbal composition that is made using complicated extraction techniques from many Aloe vera plant types. From ancient times, aloe vera has been utilized for its many medical benefits. The present study has focused on the possible health advantages of the polyherbal formulation of Aloe vera and its different components. Due to the high concentration of active substances, including polysaccharides, anthraquinones, and flavonoids, PRS-17 is thought to provide a number of medicinal advantages. Several therapeutic qualities of the polyherbal formulation have been identified, including anti-inflammatory, antibacterial, antioxidant, and immunomodulatory activities. PRS-17 could be used in the creation of novel medicines, nutraceuticals, and cosmetics.

[0007] Anti-Inflammatory Properties:

[0008] Aloe vera's Polyherbal Formulation also includes substances with anti-inflammatory qualities, which might be helpful for illnesses like arthritis. According to certain research, aloe vera may improve cardiovascular health by lowering blood pressure and cholesterol levels.

[0009] A potential anti-inflammatory, polyherbal formulation from aloe vera has historically been used to treat bums, sunburns, acne, and eczema as well as other skin disorders. The antibacterial, anti- inflammatory, and antioxidant characteristics of the polyherbal Aloe vera formulation may aid in promoting wound healing, reducing inflammation, and preventing infections.

[0010] Laxative Effects:

[0011] Moreover, it helps with digestion and relieves constipation. The Aloe vera polyherbal formulation is advantageous for illnesses like inflammatory bowel disease since it have laxative effects and help lessen inflammation in the digestive tract.

[0012] Immunomodulatory Effects:

[0013] Aloe vera poly herbal formulation has been demonstrated to have immunomodulatory properties, which means it can help control how the immune system reacts. The aloe vera polyherbal formulation may support immune system development and hold promise for the treatment of several autoimmune illnesses.

[0014] Anti-Glycemic Effects:

[0015] PRS-17, a polyherbal Aloe vera formulation, comprises active ingredients that have been shown to have a number of medicinal advantages, including possible effects on blood sugar regulation in diabetics. Aloe vera may help increase insulin sensitivity and glucose absorption in cells, which may result in better blood sugar regulation, according to some research.

[0016] Further study is required to validate the benefits of aloe vera on blood sugar regulation because the available information is currently scant and contradictory. Aloe vera should be used with caution in those taking these medications due to the possibility of interactions with some drugs used to control diabetes, such as insulin or oral hypoglycemic agents.

[0017] Anthraquinones as a natural component:

[0018] Aloe vera is a valuable natural component in many medicinal, cosmetic, and nutraceutical applications due to the anthraquinones it contains. It is crucial to remember that the anthraquinones included in aloe vera may interact with several drugs, including diuretics, cardiac glycosides, and other laxatives, and may even have negative side effects. Therefore, it is recommended to consult with a healthcare provider before using Aloe vera products containing anthraquinones.

[0019] Lectins as another important component:

[0020] Lectins are proteins that are one of the active ingredients in aloe vera and provide a number of health advantages. Aloe vera contains lectins that may attach to certain sugars on the surface of cells, including bacteria and viruses. Lectins have antiviral and antibacterial properties thanks to this characteristic. Lectins in aloe vera have been discovered to prevent the spread and replication of viruses such the influenza, herpes simplex, and HIV. This could be because the lectins can obstruct the virus's ability to attach to host cells and impede entrance.

[0021] Acemannan as another important component:

[0022] Acemannan also has antiviral properties, which means it can stop viruses from multiplying and spreading. According to studies, acemannan can stop the growth of a number of viruses, including the influenza virus, herpes simplex virus, and HIV. This could be a result of its capacity to obstruct the virus's attachment to host cells and impede penetration.

[0023] Moreover, it has been discovered that acemannan has wound-healing abilities. It can increase collagen synthesis, promote skin cell proliferation and migration, and speed up tissue regeneration. This makes it a useful component in a variety of topical treatments for bums, wounds, and other skin disorders.

[0024] With the method of extraction described in the patent, the concentration of these active ingredients increases and potentiated the effects already known.

[0025] OBJECT OF THE INVENTION: The main object of the present invention is to provide a novel polyherbal formulation effective as an antimicrobial, anti-inflammatory and anti-viral.

[0026] Another object of the present invention is to provide a polyherbal formulation for antioxidant.

[0027] Another object of the present invention is to provide a Polyherbal Formulation to have antiinflammatory properties, which may be beneficial for conditions such as arthritis.

[0028] SUMMARY OF THE INVENTION:

[0029] One embodiment of the present invention provides a herbal formulation PRS-17 comprising Aloe Vera and Guggulu (Commiphora Wightii), in an amount of 25-65 % weight of the composition

[0030] Another embodiment of the present invention is to disclose a novel polyherbal compound PRS- 17 comprising each of Aloe Vera 15% w / w of the compositions and Guggulu (Commiphora Wightii) 15 % w / w of the compositions, along with suitable excipients selected from dicalcium phosphate (DCP) in an amount of 45% by weight of the composition, gelatin in an amount of 7.5% by weight of the composition, starch in an amount of 7.5% by weight of the composition, carboxymethyl cellulose (CMC) in an amount of 2% by weight of the composition, magnesium stearate in an amount of the 4% by weight of the composition, talc in an amount of the 4% by weight of the composition.

[0031] The present invention is the carriers selected from a group comprising of diluent, binder, glidant and lubricant.

[0032] The present invention provides the formulation may additionally comprise of auxiliary, stabilizing, thickening, flavouring, fragrance and colouring agents.

[0033] BRIEF DESCRIPTION OF THE DRAWINGS:

[0034] FIG. l illustrates a flow of process flow chart depicting the step-by-step process of the preparation of herbal formulation according to the present invention.

[0035] DETAILED DESCRIPTION OF THE INVENTION:

[0036] As used in the present specification, the following words and phrases are generally intended to have the meanings as set forth below, except to the extent that the context in which they are used indicates otherwise. It is to be noted that as used herein and in the claims, the singular forms “a,” “an” and “the” include plural referents unless the context clearly dictates otherwise. Thus, for example, a reference to “a pharmaceutically acceptable carrier in a composition includes two or more pharmaceutically acceptable carriers, and so forth.

[0037] “Comprising is intended to mean that the compositions and methods include the recited elements, but do not exclude others. “Consisting essentially of when used to define compositions and methods, shall mean excluding other elements of any essential significance to the combination for the intended use.

[0038] The term "comprising", which is synonymous with "including", "containing", or "characterized by" here in defined as being inclusive or open-ended, and does not exclude additional, unrecited elements or method steps, unless the context clearly requires otherwise.

[0039] The present invention was aimed to develop oral herbal preparation comprising natural herbal extracts as active ingredients and pharmaceutically acceptable excipients or carriers.

[0040] The present invention is to provide oral herbal preparation comprising Aloe Vera and Guggulu extract as natural herbal extracts and pharmaceutically acceptable excipients or carriers.

[0041] The present invention is to provide an efficient process for the preparation of oral herbal preparation comprising the steps of macerating, dissolving, mixing, and packing.

[0042] The term "active ingredients" of the present invention are used to relieve from pain conditions. Preferably used active ingredients of Aloe vera and Guggulu extract.

[0043] Another embodiment of the present invention is to disclose a novel polyherbal compound PRS- 17 comprising each of Aloe Vera 15% w / w of the compositions and Guggulu (Commiphora Wightii) 15 % w / w of the compositions, along with suitable excipients selected from dicalcium phosphate (DCP) in an amount of 45% by weight of the composition, gelatin in an amount of 7.5% by weight of the composition, starch in an amount of 7.5% by weight of the composition, carboxymethyl cellulose (CMC) in an amount of 2% by weight of the composition, magnesium stearate in an amount of the 4% by weight of the composition, talc in an amount of the 4% by weight of the composition.

[0044] The present invention is the carriers selected from a group comprising of diluent, binder, glidant and lubricant.

[0045] The present invention provides the formulation may additionally comprise of auxiliary, stabilizing, thickening, flavouring, fragrance and colouring agents.

[0046] The active ingredients in Aloe vera contribute to its antiglycemic, anti-inflammatory, immunomodulatory, and laxative effects that are primarily based on its rich array of bioactive compounds including polysaccharides, anthraquinones, and glycoproteins. Here’s a detailed look at these components:

[0047] 1. Polysaccharides (notably Acemannan) :

[0048] • Immunomodulatory Effects: Acemannan enhances the immune system's responsiveness and modulates its activity, potentially beneficial in managing autoimmune diseases.

[0049] • Antiglycemic Effects: This compound has shown potential in regulating blood glucose levels by enhancing cellular uptake of glucose and improving insulin sensitivity.

[0050] 2. Anthraquinones (including Aloe-emodin and Aloin):

[0051] • Laxative Effects: Anthraquinones stimulate water and electrolyte secretion in the colon, promoting bowel movements and easing constipation.

[0052] • Anti-inflammatory Effects: These compounds inhibit pathways that trigger inflammation, helping reduce inflammatory responses in conditions like arthritis.

[0053] 3. Lectins:

[0054] • Immunomodulatory Effects: Aloe vera lectins can modulate immune functions, which may be useful in treating infections and possibly other immune-related conditions.

[0055] 4. Glycoproteins:

[0056] • Anti-inflammatory Effects: These proteins help in reducing pain and inflammation, particularly in wound healing and bums.

[0057] In the context of genomics, epigenetics, and metabolomics, the biological activities of these compounds are influenced by how Aloe vera's genetic expression is modulated by environmental factors and its metabolic processes. Research into these areas is ongoing, aiming to optimize the therapeutic use of Aloe vera based on a deeper understanding of these complex interactions.

[0058] The integration of traditional usage with modem scientific validation continues to enhance our understanding of Aloe vera's pharmacological potential and its application in treating various ailments.

[0059] In Ayurveda, substances are evaluated based on their properties (Dravya Guna) and effects on the three doshas (Vata, Pitta, and Kapha). The active ingredients of Aloe vera can be understood within this traditional framework:

[0060] 1. Polysaccharides (notably Acemannan) :

[0061] • Dravya Guna: Sweet and cooling; they are considered nurturing and soothing.

[0062] • Dosha Effects:

[0063] • Vata: Balancing; due to its soothing properties, it can help reduce Vata's dryness and irregularity.

[0064] • Pitta: Cooling properties help soothe Pitta’s heat.

[0065] • Kapha: Generally neutral, but excessive use could potentially increase Kapha due to its heavy nature.

[0066] 2. Anthraquinones (including Aloe-emodin and Aloin):

[0067] • Dravya Guna: Bitter and cooling; these compounds are known for their strong purgative properties.

[0068] • Dosha Effects:

[0069] • Vata: Can aggravate Vata if used excessively due to its drying and strong laxative effects.

[0070] • Pitta: Cooling properties can be beneficial, but its intense action might irritate Pitta in high doses.

[0071] • Kapha: Reduces Kapha due to its drying and cleansing actions, which counteract Kapha’s tendency towards stagnation and excess fluid.

[0072] 3. Lectins:

[0073] • Dravya Guna: Pungent and cooling; lectins can bind to carbohydrates, affecting cell metabolism.

[0074] • Dosha Effects:

[0075] • Vata: Can increase Vata due to its potentially harsh, penetrating qualities.

[0076] • Pitta: Cooling nature helps balance Pitta, although its bioactivity might sometimes increase Pitta due to tissue irritation. • Kapha: Beneficial in reducing Kapha because of its penetrating and metabolizing properties.

[0077] 4. Glycoproteins:

[0078] • Dravya Guna: Sweet and cooling; these proteins help in soothing irritated tissues and healing wounds.

[0079] • Dosha Effects:

[0080] • Vata: Balancing, as they help in healing and reducing tissue dryness.

[0081] • Pitta: Cooling and soothing actions help calm Pitta inflammation.

[0082] • Kapha: Generally neutral; while soothing, they do not typically promote moisture or heaviness that could aggravate Kapha.

[0083] These Ayurvedic properties reflect a holistic understanding of how substances interact with the body's elemental energies. Aloe vera, with its versatile active ingredients, is commonly used in Ayurvedic medicine to balance the doshas, particularly useful in conditions involving excess heat or dryness, promoting healing, digestion, and overall vitality. This integration of Aloe vera into Ayurvedic practices underscores its value as a multi-faceted healing agent.

[0084] The active ingredients in Aloe vera — polysaccharides, anthraquinones, lectins, and glycoproteins — affect the doshas (Vata, Pitta, Kapha) in Ayurveda, contributing to its diverse pharmacological effects. Here is how these ingredients influence the doshas and result in antiglycemic, anti-inflammatory, immunomodulatory, and laxative effects:

[0085] 1. Antiglycemic Effects:

[0086] • Polysaccharides (Acemannan): Acemannan helps in glucose metabolism, which can balance Kapha, the dosha primarily associated with the body's physical structure and fluid balance, including insulin function. By enhancing cellular uptake of glucose and insulin sensitivity, it helps control blood sugar levels, reducing Kapha imbalance related to diabetes.

[0087] • Dosha Implication: Reducing Kapha helps mitigate conditions associated with hyperglycemia and insulin resistance.

[0088] 2. Anti-inflammatory Effects:

[0089] • Anthraquinones & Glycoproteins: These compounds possess cooling properties that pacify Pitta, the dosha associated with heat and metabolism. Inflammation is considered a Pita disorder due to excessive heat; thus, cooling agents like anthraquinones and glycoproteins help reduce inflammation.

[0090] • Lectins: Although primarily affecting immunity, the immunomodulatory properties of lectins can indirectly influence inflammation control by moderating immune response, beneficial in calming Pitta.

[0091] • Dosha Implication: By calming Pita, these components help manage inflammatory conditions such as arthritis, dermatitis, and other inflammatory ailments.

[0092] 3. Immunomodulatory Effects:

[0093] • Polysaccharides & Lectins: Both enhance the immune system's functions. Acemannan, for instance, is known to modulate immune responses, which is crucial in balancing both Kapha and Vata. Kapha governs body strength and immunity, while Vata controls movement and activity, including the circulation of immune cells.

[0094] • Dosha Implication: Modulating Kapha and Vata enhances the body's resistance to disease and adjusts the immune response to be more effective yet not overly aggressive, crucial in autoimmune conditions.

[0095] 4. Laxative Effects:

[0096] • Anthraquinones (such as Aloin): These have strong purgative properties which stimulate the large intestine, increasing water and electrolyte content in the bowel. This action reduces Kapha by eliminating excess moisture and toxins, while its drying properties can aggravate Vata if not used judiciously.

[0097] • Dosha Implication: Primarily reducing Kapha, the use of Aloe vera for its laxative effects helps in conditions like constipation, which in Ayurveda is often linked to an imbalance of Vata and Kapha.

[0098] These detailed actions on the doshas not only illustrate how Aloe vera's active ingredients function within the Ayurvedic framework but also show their potential applications in managing and treating various health conditions by balancing the body's elemental energies.

[0099] Additionally, the composition comprises Guggulu, derived from the resin of the Commiphora wightii tree and known as Indian Bdellium, is a botanical treasure renowned for its healthpromoting properties. Its active ingredients include guggulsterones, which function as steroids, contributing to the reduction of cholesterol and triglyceride levels. Essential oils within Guggulu contain terpenoids, endowing it with anti-inflammatory and analgesic properties, while flavonoids provide antioxidant benefits. Biologically, Guggulu exhibits lipid-lowering effects, effectively reducing cholesterol and triglycerides in the blood. Its anti-inflammatory properties make it valuable in the treatment of arthritis and various inflammatory conditions. Guggulu's antioxidant actions protect against oxidative stress, contributing to cellular health. Additionally, it displays antimicrobial activity against certain bacteria and fungi. Guggulu's role in thyroid regulation proves beneficial in managing hypothyroidism. Furthermore, its involvement in weight management extends to assisting in weight loss and the management of obesity.

[0100] MANUFACTURING PROCESS FOR ORAL HERBAL PREPARATION:

[0101] The polyherbal formulation is prepared by a process involving a series of steps. Firstly, the herbal ingredients are mixed with each other and blended to form a fine herbal powder. The fine herbal powder is then macerated with bio-methanol in a proportion of 1:4 and allowed to settle down for 2-5 days. After settling down, the bio-methanol fraction is separated from the mixture and subjected to evaporation at a temperature range of 65°C to 70°C. This process yields the first phase of the final extract, which is the bio-methanol soluble extract.

[0102] In the next step, sufficient quantity of Ethyl acetate is added to the settled down mixture and heated at a temperature ranging from 40°C to 80°C for 0.5 to 3 hours. This step is done to extract ethyl acetate soluble components from the herbal ingredients. After the extraction, the ethyl acetate fraction is separated from the settled down mixture and subjected to evaporation at a temperature range of 75°C to 80°C. This process yields the second phase of the final extract, which is the ethyl acetate soluble extract.

[0103] The process continues by washing the settled down mixture with sufficient quantity of water and adding bio-ethanol to the mixture. The mixture is then heated at a temperature ranging from 40°C to 70°C for 0.5 to 2 hours. After the heating process, the Bio-ethanol fraction is separated from the mixture and subjected to evaporation at a temperature of 78°C. This process yields the third phase of the final extract, which is the bio-ethanol soluble extract.

[0104] After washing out the settled down mixture obtained above, the mixture is heated with water at a suitable temperature of 100°C for 2 hours to obtain water soluble extract, which is the fourth phase of the final extract.

[0105] The final extract is obtained by mixing all four phases of the extract along with excipients, which are blended together for an acceptable form of oral administration. The present invention is explained in the form of exemplary illustrations. However, it is to be understood that the example is merely illustrative and is not to be taken as limitations upon the scope of the invention. The disclosed embodiments with various changes and modifications will be apparent to those skilled in the art and are made without departing from the scope of the invention.

[0106] The process of the present invention is now illustrated herein below with the help of the following example:

[0107] EXAMPLE - 1

[0108] The present invention relates to a polyherbal formulation comprising Aloe Vera and Guggulu, which is prepared using a unique method. The formulation comprises 15% w / w of Aloe Vera and 15% w / w of Guggulu, which are first combined and mixed together one by one. The resulting mixture is then blended into a fine herbal powder.

[0109] The next step involves macerating the fine herbal powder with 60% bio-methanol at room temperature for 5 days. After allowing the mixture to settle down, the bio-methanol fraction is separated from the settled mixture and subjected to evaporation at 68°C to obtain the biomethanol soluble extract, which is the first ingredient for the formulation of the final extract.

[0110] The settled mixture is then mixed with ethyl acetate and heated at different temperatures for different durations for extraction of ethyl acetate soluble components from the herbal ingredients. After the separation of the ethyl acetate fraction, the remaining ethyl acetate is evaporated at 78 °C for 0.5 hours to obtain the ethyl acetate soluble extract, which is the second ingredient for the formulation of the final extract.

[0111] After washing out the settled-down mixture with water, 60% bio-ethanol is added to the mixture and heated at different temperatures for different durations. After separation of the bio-ethanol fraction from the mixture, it is subjected to evaporation at 78°C to obtain bio-ethanol soluble extract, which is the third ingredient for the final extract.

[0112] The settled down mixture obtained in the above step is washed out, and the mixture is heated with water at a temperature of 100 °C for 2 hours to obtain water soluble extract, which is the fourth ingredient for the final extract.

[0113] The final extract is obtained by mixing phase 1, 2, 3, and 4 in the proportion of 21.25% to 28.75% ofphase I, 21.25% to 28.75% of phase II, 21.25% to 28.75% of phase III, and 21.25% to 28.75% of phase IV, along with the excipients. The resulting mixture is blended together to form an acceptable form of oral administration.

[0114] The herbal formulation is used in dosage of 2 mg - 16 mg / body weight for average body weight in single or divided doses per day.

[0115] ADVANTAGES OF THE PRESENT INVENTION

[0116] • The synergistic combination of natural extracts, including Aloe vera and Guggulu, aimed at enhancing therapeutic properties such as anti-microbial, anti-inflammatory, antioxidant, and immunomodulatory effects.

[0117] • PRS-17 is innovative in its combination of various herbal extracts, which are optimized in specific ratios to enhance the biological activities of the individual components. This synergistic effect potentially increases the efficacy of the formulation compared to using Aloe vera alone.

[0118] • The document mentions advanced extraction techniques that enhance the concentration and potency of active ingredients like polysaccharides, anthraquinones, and lectins from Aloe vera. These methods help in maximizing the bioavailability and therapeutic effects of the active compounds.

[0119] • The formulation is designed to act on multiple fronts including anti-inflammatory, immunomodulatory, and glycemic control. This broad spectrum of activity offers a comprehensive approach to managing various conditions, which could be more effective than targeting a single biochemical pathway.

[0120] • The innovation extends to the potential applications of the formulation, which are not limited to health supplements but may include uses in nutraceuticals, pharmaceuticals, and cosmetic products. This versatility is significant from a commercial and therapeutic perspective.

Claims

CLAIMSI CLAIM:

1. A polyherbal composition, comprising: a. Aloe Vera in an amount of 25-65% w / w of the compositions; and b. Guggulu (Commiphora Wightii) in an amount of 25-65 % w / w of the compositions along with suitable excipients selected from dicalcium phosphate (DCP) in an amount of 45% by weight of the composition, gelatin in an amount of 7.5% by weight of the composition, starch in an amount of 7.5% by weight of the composition, carboxymethyl cellulose (CMC) in an amount of 2% by weight of the composition, magnesium stearate in an amount of the 4% by weight of the composition, talc in an amount of the 4% by weight of the composition, wherein, the composition is characterized by its antimicrobial, anti-inflammatory, antioxidant, and immunomodulatory activities.

2. The polyherbal composition as claimed in claim 1, wherein the polyherbal formulation which has anti-inflammatory properties comprises of aloe vera and Guggulu in an amount of 15 % by weight of each composition.

3. The polyherbal composition as claimed in claim 1, wherein the composition improves skin health by reducing inflammation, promoting wound healing, and providing antioxidant benefits.

4. A process of preparation of a polyherbal formulation which has anti-inflammatory, antioxidant, and immunomodulatory activities, the process comprises the steps of: a. mixing the herbal ingredients Aloe Vera and Guggulu (Commiphora Wightii) with each other one by one to create a mixture; b. blending the mixture of (a) into a fine herbal powder; c. macerating the fine herbal powder with bio-methanol for 2-5 days and allowing the mixture to settle down; d. separating the bio-methanol fraction from the settled down mixture and subjecting to fraction to evaporation at 65oC to obtain the bio-methanol soluble extract to make Part I; e. taking the mixture obtained in step (d) and adding a sufficient amount of ethyl acetate to the settled-down mixture; f. heating at a temperature ranging from 40oC to 80oC for 0.5 hours to 3 hours for extraction of ethyl acetate soluble components from the herbal ingredients. g. separating the ethyl acetate fraction from the settled-down mixture;h. heating the ethyl acetate fraction and evaporating at 78oC to obtain the ethyl acetate soluble extract to make Part II. i. washing out the settled down mixture obtained in step (g) with a sufficient quantity of water and then adding 20-60% bio-ethanol to the mixture; j. heating the mixture obtained in (i) at a temperature ranging from 40°C to 70°C for 0.5 to 2 hours followed by separating the bio-ethanol fraction from the mixture. k. subjecting the bio-ethanol fraction to evaporation at a temperature of 78°C to obtain bio-ethanol soluble extract to make Part III; l. heating the settled down mixture obtained in step (k) with water at a suitable temperature of 100°C for 2 hours to obtain the water soluble extract to make Part IV; and m. mixing the Part I obtained in step (d), Part II obtained in step (h), Part III obtained in step (k), and Part IV otaied in step (1).

5. The process of preparing an herbal formulation as claimed in claim 4, wherein the formulation is made by combining 21.25% to 28.75% of part I, 21.25% to 28.75% of part II, 21.25% to 28.75% of part III, 21.25% to 28.75% of part IV, excipients, carriers and solvents.

6. The process of preparing a poly herbal formulation as claimed in claim 4, wherein the excipients of the formulation can be selected from group of dicalcium phosphate, gelatin, starch, carboxymethyl cellulose (CMC), magnesium stearate, talc or combination thereof.

7. The process of preparing an herbal formulation as recited in claim 4, wherein the said composition is formulated for oral administration.

8. The process of preparing a polyherbal composition as claimed in claim 4, wherein the carriers are selected from a group comprising of diluent, binder, glidant and lubricant.

9. The process of preparing an herbal composition as claimed in claim 4, wherein the solvents may be selected from methanol, ethanol, ethyl acetate, acetone, hexane, etc.

10. The polyherbal formulation as claimed in claim 4, wherein said pharmaceutical formulation may optionally consist of auxiliary, stabilizing, thickening, flavoring, fragrance, and coloring agents.

Citation Information

Patent Citations

  • Saccharide free, storage stable thyroid hormone active drug formulations and methods for their production

    US8779000B1

  • IN1180KO2015A